Network TV show in the works for Everyday Health

Share this article:
Everyday Health is planting its flag in network television with an ABC show that is being produced by “The Biggest Loser” creator Mark Koops.

The half-hour show, “Everyday Health,” will air as part of a three-hour block of programming following Good Morning America Saturday mornings on 95% of the nation's ABC affiliate stations, beginning in September. The concept for the show is “Extreme Makeover: Home Edition” meets “The Doctors,” a spokesperson said, and will feature patients who have sought to help others with similar conditions – for example, Jesse Billauer, a surfer rendered quadriplegic by a spinal injury who went on to start Life Rolls On, a division of the Christopher & Dana Reeve Foundation which helps surfers who have suffered spinal injuries.

The programming block, dubbed “Weekend Adventure,” includes “Jack Hanna's Wild Countdown” and “Ocean Mysteries,” and is produced by Litton Entertainment, which will manage ad sales and distribution for the show. Everyday Health co-founders Ben Wolin, CEO, and Mike Keriakos, president, are co-producing the show along with Koops.

“This show will celebrate health-related philanthropy, demonstrating how one person can make a world of difference in someone else's life,” said Keriakos.

Everyday Health will plug the show through its digital channels, which boast 28 million unique users per month, and will create a dedicated site for the show on
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Channel


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...